Waukegan D60 Wraparound Center serving more students, adults; ‘People are responding to the services we're providing'
Growing 30% from the time it opened in July until late November, LeBaron Moten, the district's deputy superintendent for operational supports and programs, said that since then, the number of referrals grew from 54 to 116.
'There has been an almost 50% increase in referrals for the Wraparound Center program,' he said.
Moten presented an update on the Wraparound Center's operations to the District 60 Board of Education's Operational Services Committee on Tuesday at the Education Service Center in downtown Waukegan, keeping the board up to date on the efforts of the facility.
Opening with two service providers in July — A Safe Pace focusing on sexual abuse and domestic violence, and Community Youth Network (CYN) offering mental health social support and social-emotional counseling — a third service, GRO Community, joined in February.
GRO provides 'trauma-informed mental health services and behavioral support,' according to information on the district's website referenced by Moten. Bridget Dotson, the director of the center, said GRO focuses more on male students and men.
'Their specialty is developing boys into men,' Dotson said in February. 'They are already known in the community, and they will enable us to enlarge the scope of our work in the community and the scope of the Wraparound Center.'
Dotson said after the meeting that approximately 70% of the people receiving services are students in the district's elementary and middle schools, as well as Waukegan High School, while the others are community members. The primary reason is general mental health.
Tirzah Norwood-Jones, the Wraparound Center's manager, said she is pleased with the growth, particularly in the last few months, where it has continued to accelerate.
'We are extending our reach,' Norwood-Jones said. 'We're going to keep it up.'
Board member Christine Lensing said at the meeting that she and her colleagues should tell all the people they can about the Wraparound Center since it serves residents of the city as well as students in the schools.
'We should be promoting this as much as we can in the community because it's not only for our students, but we have adults that use the services and, from my understanding, things are really going well,' Lensing said. 'People are responding to the services we're providing.'
When visiting schools, Lensing said board members, as well as administrators, should talk to school leaders. Collaboration between the schools and the Wraparound Center is part of the overall process of helping students.
'We should make sure we're promoting this,' Lensing said. 'It is a big investment, but it is a big investment because our community needs it.'
Operating by appointment only, Dotson said students can refer themselves or a counselor can help them with the process. They can do it online through the district's secure system. Adults can go to a different website and use the QR code, or they can make an appointment over the phone.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
Worcester health and human services commissioner to retire after 10 years
After 10 years of serving as Worcester's health and human services (HHS) commissioner, Dr. Matilde Castiel will retire on Sept. 30, City Manager Eric D. Batista announced on Monday. 'I am retiring after 10 years. It's not easy for me to say those words because this work, and this city, have been my heart for a decade,' Castiel said in a press release from Batista's office. 'I have had the extraordinary privilege of serving a community I love alongside people who inspire me every single day. Together, we have faced enormous challenges and built bold, beautiful solutions. I have seen what's possible when compassion leads, when equity guides, and when justice is more than a goal but truly is a practice.' Castiel immigrated from Cuba to the United States in 1962, according to the press release. For 36 years, she has worked as an internal medicine physician in Worcester, spending time at UMass Memorial Medical Center and Family Health Center of Worcester. She is also an associate professor of internal medicine, family medicine and psychiatry at the UMass Chan Medical School. In 2015, then City Manager Ed Augustus named Castiel to serve as the HHS commissioner. Castiel's appointment came at a time when Worcester reconstituted its HHS department, which was previously eliminated in 2009 as part of budget cuts. As HHS commissioner, Castiel helped establish the city's Housing First Coordinating Council, opioid task force and the mayor's mental health task force, the press release reads. Recently, she worked with UMass Chan Medical School to create the Worcester Integrated Health Data Exchange — a partnership among health care agencies that provide Worcester health data to help better understand health inequities, trends, risk factors and outcomes, according to the press release. 'I want to congratulate Dr. Castiel on an incredibly impactful tenure as a public servant to the City of Worcester,' Batista said in the press release. 'Her dedication to this community has truly been inspiring – from her work to institute a syringe exchange program to launching a Housing First Coordinating Council to her leadership throughout the COVID-19 pandemic, running equity-based vaccination campaigns and shelters — she has proven herself as a compassionate problem solver and will leave a lasting legacy.' With Castiel departing, Batista's administration will 'explore' options for the role of HHS commissioner and will relay its plan before Castiel's departure, according to the press release. More Worcester Stories New Jersey man charged with assault in Fitchburg fatal shooting 2-year-old in critical condition after falling from Worcester window Disappointing jobs numbers mean 'this is Donald Trump's economy right now' say McGovern, Neal Read the original article on MassLive. Solve the daily Crossword
Yahoo
4 days ago
- Yahoo
Could a single shot at birth shield kids from HIV for years?
There's potentially exciting news from a trial conducted in monkeys: A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at least three years. Of course, studies conducted in animals don't always pan out in humans. But scientists say that if it does, it could save the lives of babies and children still imperiled by HIV. The study authors estimate that more than 100,000 children worldwide (largely in subSaharan Africa) are believed to contract HIV soon after birth, primarily via breastfeeding with an HIV+ mother. "Nearly 300 children are infected with HIV each day," said lead author Dr. Amir Ardeshir, associate professor of microbiology and immunology at the Tulane National Primate Research Center in New Orleans. "This approach could help protect newborns in high-risk areas during the most vulnerable period of their lives." His team published its findings July 30 in Nature. It noted that the new work hinges on the notion that in the first few weeks of a primate's life -- humans are primates, too -- the body's immune system is naturally more tolerant of "invaders," including gene therapies. The research focused on a tried-and-true form of HIV-fighting gene therapy. It works by programming cells to continuously produce HIV-fighting antibodies. The gene therapy was piggybacked onto a harmless adeno-associated virus (AAV) to help deliver it to the muscle cells of newborn rhesus macaques. Muscle cells were chosen because they are particularly long-lived, Ardeshir's team explained. The gene therapy instructs these cells to produce broadly neutralizing antibodies, or bNAbs, which are capable of neutralizing multiple strains of HIV. It's not the first time bNAbs have been used in gene therapy to fight HIV. However, in prior trials repeat injections were required to keep the immune system vigilant. In the new trial, "we turn these muscle cells -- which are long-lived -- into micro factories that just keep producing these antibodies," Ardeshir explained. When such an approach is used in older monkeys, however, the animals' robust immune systems turn against the therapy, shutting it down. That didn't happen when Ardeshir's team introduced it during a macaque's first few weeks of life. All of the monkeys who got a single shot of bNAbs therapy soon after birth were shielded from infection with HIV for at least three years, with no need for a booster. Tulane researchers said that's roughly the equivalent of a treatment that could ward off HIV in humans deep into adolescence. If the gene therapy was delivered even a bit later -- 8 to 12 weeks after birth -- the young monkey's more developed immune system swung into action to fight it, eroding its effectiveness. Giving the shot soon after birth seemed key, Ardeshir said. "This is a one-and-done treatment that fits the critical time when these mothers with HIV in resource-limited areas are most likely to see a doctor," he noted in a Tulane news release. "As long as the treatment is delivered close to birth, the baby's immune system will accept it and believe it's part of itself." Will it work in human babies? That's not entirely clear, since it's possible infants might be less amenable than monkeys to therapies that are delivered via AAV, the team said. The monkey trial also used only one strain of simian-human immunodeficiency virus, which is similar in some ways to HIV but may not reflect the variety of circulating strains of HIV strains. Still, the research team is hopeful. Giving families a one-shot preventive tool to protect their children would be especially useful in areas where access to repeat medical treatments can be tough, the researchers said. "Nothing like this was possible to achieve even 10 years ago," Ardeshir said. "This was a huge result, and now we have all the ingredients to take on HIV." More information Find out more about HIV and AIDS at the U.S. Centers for Disease Control and Prevention (CDC). SOURCE: Tulane University, news release, July 30, 2025 Copyright © 2025 HealthDay. All rights reserved.
Yahoo
4 days ago
- Yahoo
A single injection for newborns could protect them against HIV for years, study suggests
A single injection at birth could shield children from HIV for years, a study has suggested. The study is one of the first to show that the first weeks of life offer a critical window where the immune system is naturally more tolerant, meaning it is the optimal time to deliver gene therapies that would otherwise be rejected at older ages. Researchers hope the gene therapy jab could be used in the future to fight against paediatric infections in high-risk areas. 'Nearly 300 children are infected with HIV each day,' said first author Amir Ardeshir, associate professor of microbiology and immunology at the Tulane National Primate Research Center in the US. 'This approach could help protect newborns in high-risk areas during the most vulnerable period of their lives.' The study, published in the journal Nature, created a gene therapy that programs cells to produce HIV-fighting antibodies. An animal study that tested the injection on non-human primates found it protected them from infection for at least three years without the need for a booster shot. But this was only if the injection was administered in the first month of life. In comparison, those that received the gene therapy between eight and 12 weeks after birth did not tolerate the treatment, study authors explain. 'This is a one-and-done treatment that fits the critical time when these mothers with HIV in resource-limited areas are most likely to see a doctor,' Dr Ardeshir said. 'As long as the treatment is delivered close to birth, the baby's immune system will accept it and believe it's part of itself.' Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health Organization (WHO). But if they do not receive medication, the rate of transmission of HIV from the mother to her child either during pregnancy, labour, delivery or breastfeeding ranges between 15 per cent and 45 per cent, according to WHO data. Although antiviral treatments can suppress the virus and limit transmission, adherence to treatment and doctor visits decline after childbirth, particularly in areas with limited access to healthcare, the study authors noted. This gene therapy uses a harmless virus that can deliver genetic code to cells, but is different to a vaccine. This virus was injected into muscle cells and delivered instructions to produce antibodies that are capable of neutralising multiple strains of HIV. Researchers explained that previous studies have found repeated infusions of the injection are needed for it to work. But by injecting it into muscle cells, researchers say they become 'micro-factories that just keep producing these antibodies'. Newborns showed greater tolerance to the jab, which prevented infection during breastfeeding. However, older infants and juveniles were more likely to have produced anti-drug antibodies that shut down the treatment. In addition, exposing a foetus to the antibodies from the gene therapy before birth helps older infants accept the therapy. However, because it has only been tested on animals, researchers still do not know if it will work on human children. If successful, this treatment could dramatically reduce mother-to-child HIV transmission rates in high-risk regions such as sub-Saharan Africa, where 90 per cent of paediatric HIV cases can be found. 'Nothing like this was possible to achieve even 10 years ago,' Dr Ardeshir said. 'This was a huge result, and now we have all the ingredients to take on HIV.'
